Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease and other pulmonary vascular disorders
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Kobayashi, M. Hanaoka, Y. Droma, K. Kogashi, K. Urushibata, K. Kubo (Matsumoto, Japan). The status of venous vasodilator, vasoconstrictors in high-altitude pulmonary edema susceptible subjects under hypoxic exposure. Eur Respir J 2010; 36: Suppl. 54, 4532

Member's Comments

No comment yet.

Related content which might interest you: Effect of normobaric hypoxia on pulmonary hemodynamics in patients with precapillary pulmonary hypertension Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension Year: 2017 Acetazolamide and chronic hypoxia: effects on haemorheology and pulmonary haemodynamics Source: Eur Respir J 2012; 40: 1401-1409 Year: 2012 Dexamethasone and tadalafil prophylaxis prevents both excessive pulmonary constriction and high altitude pulmonary edema in susceptible subjects Source: Eur Respir J 2004; 24: Suppl. 48, 110s Year: 2004 Identification of individuals susceptible to high-altitude pulmonary oedema at low altitude Source: Eur Respir J 2005; 25: 545-551 Year: 2005 High-altitude disease Source: Respipedia Article Year: 2017 Improvement of exercise capacity in monocrotaline induced pulmonary hypertension by the phosphodiesterase inhibitor Vardenafil Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals Year: 2006 Dag-dependent regulation of trpc6 in hypoxic pulmonary vasoconstriction Source: Annual Congress 2009 - Pathobiology of pulmonary vascular diseases Year: 2009 Effects of Sildenafil on hypoxic pulmonary vasoconstriction in dogs Source: Eur Respir J 2001; 18: Suppl. 33, 490s Year: 2001 Response to hypoxia of pulmonary arteries in chronic obstructive pulmonary disease: an in vitro study Source: Eur Respir J 2002; 20: 332-338 Year: 2002 Haemodynamics during vasodilator test comparing urapidil and nicardipine to NO in pulmonary arterial hypertension Source: Annual Congress 2005 - Treatment of pulmonary arterial hypertension Year: 2005 Sildenafil enhances the pulmonary vasodilatory response to inhaled iloprost in experimental pulmonary hypertension Source: Eur Respir J 2002; 20: Suppl. 38, 24s Year: 2002 Pulmonary hypertension in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 21: 892-905 Year: 2003 The effect of chronic dosing of riociguat on acute hypoxic pulmonary vasoconstriction in respiratory disease Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Acute vasodilator response in different forms of pre-capillary pulmonary hypertension Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013 Acute pulmonary vasoreactivity to beraprost in patients with severe pulmonary hypertension Source: Eur Respir J 2002; 20: Suppl. 38, 597s Year: 2002 Iloprost for pulmonary vasodilator testing in idiopathic pulmonary arterial hypertension Source: Eur Respir J 2009; 33: 1354-1360 Year: 2009 Increase of oxidative stress and pulmonary arterial inflammatory remodeling under high-flow conditions in experimental pulmonary hypertension Source: Annual Congress 2007 - Pulmonary circulation Year: 2007 Hypoxic pulmonary vasoconstriction in COPD-associated pulmonary hypertension: been there, done that? Source: Eur Respir J, 50 (1) 1701191; 10.1183/13993003.01191-2017 Year: 2017 Single arterial occlusion to locate resistance in patients with pulmonary hypertension Source: Eur Respir J 2003; 21: 31-36 Year: 2003